In this article, the authors report two patients with advanced NSCLC harboring an STK11/LKB1 mutations who presented a complete response to nivolumab treatement.
Ernest Nadal, Simon Heeke, Jonathan Benzaquen, Noelia Vilariño, Arturo Navarro, Daniel Azuara, Mar Varela, Josiane Otto, Nuria Baixeras, David Shahbazian, Pascal Puchois, Sarah E. Church, Thomas H. Smith, Elisabeth Lanteri, Marius Ilié, Paul Hofman